D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2,
D-phenylalanyl-cysteinyl-tyrosyl-D-tryptophyl-lysyl-valyl-cysteinyl-tryptophanamide,
Octastatin,
RC 160,
RC-160,
vapreotide,
Vapreotide,
Vapreotide acetate,
103222-11-3,
Sanvar IR,
RC 160,
CCRIS 6495,
Vapreotide [USAN:INN],
C57H70N12O9S2,
D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2->7)-disulfide,
AC1L2FXK,
Vapreotide (USAN/INN),
SCHEMBL6369050,
BDBM82464,
D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide cyclic (2-7)-disulfide,
L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2->7)-disulfide,
L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide,
CAS_71306,
NSC_71306,
AKOS015896024,
AN-7497,
LS-171852,
FT-0652516,
D06281,
L001100,
I06-1827,
(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-N-((S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide,
(4R,7S,10S,13S,16S,19R)-10-(4-aminobutyl)-N-[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide,
10-(4-aminobutyl)-N-[1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[(2-amino-3-phenylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide,
10-(4-aminobutyl)-N-[2-amino-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]-19-[(2-amino-3-phenyl-propanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide,
13-((1H-indol-3-yl)methyl)-N-(1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-19-(2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,
Vapreotida,
Vapreotidum,
Docrised (TN),
Vapreotidum [INN-Latin],
Vapreotida [INN-Spanish],
D07DSQ,
UNII-2PK59M9GFF,
Vapreotide [USAN:INN:BAN],
BMY 41606,
CID71306,
AR-1B9977,
ACN-049479,
C57-H70-N12-O9-S2,
,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide,
10-(4-aminobutyl)-n-[1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-16-(4-hydroxybenzyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(phenylalanylamino)-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide,
103667-11-4,